Stock Events

Stock Events

Indivior Pharmaceuticals 

$40.53
69
+$0.02+0.04% Friday 20:00
-$0.13-0.33%Friday 23:34After hours

Statistics

Day High
40.57
Day Low
40.5
52W High
42.81
52W Low
16.69
Volume
31,977
Avg. Volume
-
Mkt Cap
4.79B
P/E Ratio
20.77
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 16
$0.10
Oct 15
$0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

4AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.22
0.47
0.71
0.96
Expected EPS
0.8894
Actual EPS
N/A

Financials

16.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.24BRevenue
210MNet Income

Analyst Ratings

46.00Average Price Target
The highest estimate is 46.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INDV. It's not an investment recommendation.
NVIDIA
8
NVDA
Broadcom
8
AVGO
Amazon
7
AMZN
Microsoft
5
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.37B
Teva Pharmaceutical Industries manufactures generic drugs, including those for opioid addiction treatment, directly competing with Indivior's products.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its Janssen Pharmaceuticals division, offers products that compete in the opioid addiction treatment market.
Alkermes
ALKS
Mkt Cap8.66B
Alkermes plc provides addiction treatment products, including those for opioid dependence, which competes with Indivior's offerings.
DaVita
DVA
Mkt Cap14.94B
Dr. Reddy's Laboratories produces generic medication, including those for opioid addiction, competing with Indivior's Suboxone.
Novartis
NVS
Mkt Cap293.94B
Novartis AG, through its Sandoz division, offers generic versions of drugs that compete with Indivior's addiction treatment products.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. has a portfolio of drugs that can be used in the treatment of addiction, potentially competing with Indivior's products.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie Inc. engages in the development of pharmaceuticals that could compete with Indivior's treatments for opioid dependence.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. has a diverse drug portfolio that could include treatments competing with Indivior's addiction therapy products.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb Company offers a range of pharmaceutical products that may compete with Indivior's opioid addiction treatments.

About

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Show more...
CEO
Mr. Joseph J. Ciaffoni
Employees
838
Country
United Kingdom
ISIN
US45579U1097

Listings

MU
DE
2IVA.MU
STU
DE
2IV.STU
BOATS
BOATS
INDV.BOATS
XNAS
US
INDV

0 Comments

Share your thoughts

FAQ

What is Indivior Pharmaceuticals stock price today?▼
The current price of INDV is $40.53 USD — it has increased by +0.04% in the past 24 hours. Watch Indivior Pharmaceuticals stock price performance more closely on the chart.
What is Indivior Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Indivior Pharmaceuticals stocks are traded under the ticker INDV.
Is Indivior Pharmaceuticals stock price growing?▼
INDV stock has fallen by -0.04% compared to the previous week, the month change is a -3.12% fall, over the last year Indivior Pharmaceuticals has showed a +136.44% increase.
What is Indivior Pharmaceuticals market cap?▼
Today Indivior Pharmaceuticals has the market capitalization of 4.79B
When is the next Indivior Pharmaceuticals earnings date?▼
Indivior Pharmaceuticals is going to release the next earnings report on August 04, 2026.
What were Indivior Pharmaceuticals earnings last quarter?▼
INDV earnings for the last quarter are 0.96 USD per share, whereas the estimation was 0.66 USD resulting in a +45.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Indivior Pharmaceuticals revenue for the last year?▼
Indivior Pharmaceuticals revenue for the last year amounts to 1.24B USD.
What is Indivior Pharmaceuticals net income for the last year?▼
INDV net income for the last year is 210M USD.
Does Indivior Pharmaceuticals pay dividends?▼
Yes, INDV dividends are paid semi-annual. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Indivior Pharmaceuticals have?▼
As of July 26, 2026, the company has 838 employees.
In which sector is Indivior Pharmaceuticals located?▼
Indivior Pharmaceuticals operates in the Health & Wellness sector.
When did Indivior Pharmaceuticals complete a stock split?▼
Indivior Pharmaceuticals has not had any recent stock splits.
Where is Indivior Pharmaceuticals headquartered?▼
Indivior Pharmaceuticals is headquartered in North Chesterfield, United Kingdom.